BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10410728)

  • 1. Nitric oxide in the pathogenesis of Parkinson's disease.
    Gerlach M; Blum-Degen D; Lan J; Riederer P
    Adv Neurol; 1999; 80():239-45. PubMed ID: 10410728
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide and basal ganglia degeneration.
    Rose S; MacKenzie GM; Jenner P
    Adv Neurol; 1999; 80():247-57. PubMed ID: 10410729
    [No Abstract]   [Full Text] [Related]  

  • 3. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT; Jackson-Lewis V; Vukosavic S; Mandir AS; Vila M; McAuliffe WG; Dawson VL; Dawson TM; Przedborski S
    Nat Med; 1999 Dec; 5(12):1403-9. PubMed ID: 10581083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOS knockouts and neuroprotection.
    Grünewald T; Beal MF
    Nat Med; 1999 Dec; 5(12):1354-5. PubMed ID: 10581072
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide and reactive oxygen species in Parkinson's disease.
    Tieu K; Ischiropoulos H; Przedborski S
    IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide in Parkinson's disease.
    Zhang L; Dawson VL; Dawson TM
    Pharmacol Ther; 2006 Jan; 109(1-2):33-41. PubMed ID: 16005074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and neurological disorders.
    Duncan AJ; Heales SJ
    Mol Aspects Med; 2005; 26(1-2):67-96. PubMed ID: 15722115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.
    Knott C; Stern G; Wilkin GP
    Mol Cell Neurosci; 2000 Dec; 16(6):724-39. PubMed ID: 11124893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammatory processes in Parkinson's disease.
    Hunot S; Hirsch EC
    Ann Neurol; 2003; 53 Suppl 3():S49-58; discussion S58-60. PubMed ID: 12666098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, S-nitrosylation and neurodegeneration.
    Chung KK; Dawson TM; Dawson VL
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase regulation and diversity: implications in Parkinson's disease.
    Kavya R; Saluja R; Singh S; Dikshit M
    Nitric Oxide; 2006 Dec; 15(4):280-94. PubMed ID: 16934505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nitric oxide, neurodegeneration, and Parkinson's disease].
    Dzoljić E; Nesić Z; Stojanović R; Divac N; Todorović Z; Vucković S; Kostić V; Prostran M
    Vojnosanit Pregl; 2005 Oct; 62(10):751-6. PubMed ID: 16305103
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
    Lee DY; Oh YJ; Jin BK
    Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in inflammatory diseases.
    Sharma JN; Al-Omran A; Parvathy SS
    Inflammopharmacology; 2007 Dec; 15(6):252-9. PubMed ID: 18236016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of astroglial cell-derived nitric oxide and prostanoids in neurodegenerative disorders.
    Mollace V; Muscoli C; Nisticò G
    Funct Neurol; 1997; 12(3-4):199-203. PubMed ID: 9218977
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxide.
    Youdim MB; Lavie L; Riederer P
    Ann N Y Acad Sci; 1994 Nov; 738():64-8. PubMed ID: 7530428
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of cell death in experimental models of Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide synthase and NMDA receptor expressions in cavernoma tissues with epileptogenesis.
    Kamida T; Takeda Y; Fujiki M; Abe T; Abe E; Kobayashi H
    Acta Neurol Scand; 2007 Dec; 116(6):368-73. PubMed ID: 17986094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide as a mediator of nucleus pulposus-induced effects on spinal nerve roots.
    Brisby H; Byröd G; Olmarker K; Miller VM; Aoki Y; Rydevik B
    J Orthop Res; 2000 Sep; 18(5):815-20. PubMed ID: 11117305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiology and pathophysiology of nitric oxide in the brain.
    Guix FX; Uribesalgo I; Coma M; Muñoz FJ
    Prog Neurobiol; 2005 Jun; 76(2):126-52. PubMed ID: 16115721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.